Clearmind Medicine (CMND) Assets (QoQ) (2023 - 2026)
Clearmind Medicine (CMND) Assets (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Clearmind Medicine | 540,515.55 | -13.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 30.33% |
| Jan 31, 2026 | 83.19% |
| Oct 31, 2025 | 53.24% |
| Jul 31, 2025 | -23.37% |
| Apr 30, 2025 | -21.33% |
| Jan 31, 2025 | -9.24% |
| Oct 31, 2024 | -11.23% |
| Jul 31, 2024 | -7.60% |
| Apr 30, 2024 | -12.40% |
| Jan 31, 2024 | 69.61% |
| Oct 31, 2023 | 32.64% |
| Jul 31, 2023 | -25.15% |
| Apr 30, 2023 | 30.14% |
| Jan 31, 2023 | 442.52% |